Integrated Ultrasound-Derived Fat Fraction and 2D/4D HeartAI for Cardiovascular Risk Management in Patients With MASLD
Starting soon
Conditions studied: MASLD, Cardiovascular (CV) Risk, Subclinical Cardiovascular Impairments
In brief
This prospective observational cohort study aims to evaluate the association between liver fat fraction measured by ultrasound-derived fat fraction (UDFF) and cardiac functional parameters assessed by 2D and 4D HeartAI in adult patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Participants will undergo baseline assessment and repeat evaluations at 6, 12, and 36 months. The study will assess the diagnostic performance of integrated UDFF-HeartAI analysis for detecting subclinical cardiac abnormalities and identify predictors of cardiovascular risk progression and major adverse cardiovascular events in patients with MASLD.
Key facts
- Study ID
- NCT07545343
- Run by
- First Affiliated Hospital, Sun Yat-Sen University
- People needed
- 700
- Starts
- 2026-06-01
- Expected to finish
- 2030-05-31
- Last updated by the study team
- 2026-04-22
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults aged 18 to 75 years
- Diagnosis of MASLD based on imaging or biopsy
- Presence of at least one cardiometabolic risk factor, such as BMI ≥25 kg/m², type 2 diabetes mellitus, or dyslipidemia
- No contraindication to ultrasound imaging
You may not qualify if…
- Significant alcohol consumption: >20 g/day for women or >30 g/day for men Secondary causes of hepatic steatosis, such as viral hepatitis or autoimmune liver disease
- Known advanced heart failure (New York Heart Association class III-IV)
- Recent cardiovascular event within 6 months
- Pregnancy
- Inability to complete follow-up
Where it is running
- The First Affiliated Hospital, Sun Yat-sen University — Guangzhou, Guangdong, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.